görtler analytical services gmbh in Vaterstetten in Munich, part of the GBA Group, is now called GBA Analytical Services GmbH.

We now also offer our service in environmental analysis at our sales location in Stuttgart. We are at your disposal with competent advice, professional sampling and the acceptance of your samples.

The main focus of the Stuttgart location is on the following areas:

• Soil, construction waste and materials (sampling, analysis)
• Drinking water, cooling water and bath water (sampling, analysis)

You can rely on fast turnaround times, accredited procedures and quality-assured results, adherence to deadlines and the excellent advice of GBA Group on site in Stuttgart.

Graz, April 16th: The Hygienicum Institute for Food Safety and Hygiene in Graz has become the first company in the GBA GROUP to offer COVID-19 testing using the PCR method on samples from nose and throat swabs. The company’s testing capacity will be made available for the public healthcare system in order to process the PCR tests for COVID-19 in accordance with the national testing plan. In addition, tests will also be offered to private individuals and companies.

Elisabeth Lackner now knows her way around the conference facilities at the legendary Westin St. Francis luxury hotel, centrally located on San Francisco's Union Square, with a glass elevator overlooking the city. For years she has been attending the most important pharmaceutical conference there, which the US investment conference JP Morgan always organizes at the beginning of January. In the corridors, she welcomes industry colleagues from all over the world and follows with great interest the fact that this year again several CEOs took the time to talk about the most important pharmaceutical trends in the US election year. "We have become so important that we have to be present at this important industry event," explains the petite pharmaceutical entrepreneur confidently.

Press Release

Security of supply during the coronavirus crisis: ABF Pharmaceutical Services classified as "critical infrastructure" by the Federal Chancellery

"The classification of our company as a ‘critical infrastructure’ is very important for our business partners in the pharmaceutical and biotech industry as well as for patients and doctors, especially during the current coronavirus crisis. This is because the classification ensures that our operations can continue even in the event of a complete shutdown of the economy and that we thus would be able to continue to fulfill our mandate to supply drugs critical to human health," said Dr Elisabeth Lackner, Chief Executive Officer of ABF Pharmaceutical Services and GBA Group Pharma.